Efficacy and safety of continuing sitagliptin when initiating insulin therapy in subjects with type 2 diabetes

被引：0
|
作者：
Roussel, R. [1 ]
Duran-Garcia, S. [2 ]
Zhang, Y. [3 ]
Shah, S. [3 ]
Darmiento, C. [3 ]
Shankar, R. R. [3 ]
O'Neill, E. A. [3 ]
Golm, G. T. [3 ]
Lam, R. L. H. [3 ]
Gantz, I. [3 ]
Kaufman, K. D. [3 ]
Engel, S. S. [3 ]
机构：
[1] Grp Hosp Bichat, Paris, France
[2] Valme Univ Hosp, Med Sch, Seville, Spain
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Continuing Sitagliptin when Initiating Insulin Therapy in Subjects with Type 2 Diabetes Mellitus
    Roussel, Ronan
    Duran-Garcia, Santiago
    Zhang, Yilong
    Shah, Suneri
    Darmiento, Carolyn
    Shankar, R. Ravi
    O'Neill, Edward A.
    Golm, Gregory T.
    Lam, Raymond L.
    Gantz, Ira
    Kaufman, Keith D.
    Engel, Samuel S.
    DIABETES, 2018, 67
  • [2] Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
    Vilsboll, T.
    Rosenstock, J.
    Yki-Jarvinen, H.
    Cefalu, W. T.
    Chen, Y.
    Luo, E.
    Musser, B.
    Andryuk, P. J.
    Ling, Y.
    Kaufman, K. D.
    Amatruda, J. M.
    Engel, S. S.
    Katz, L.
    DIABETES OBESITY & METABOLISM, 2010, 12 (02): : 167 - 177
  • [3] Study of Efficacy and Safety of Sitagliptin in Patients of Type 2 Diabetes when Added to Insulin Therapy Alone or With Metformin
    Singh, Devendra P.
    Srivastava, Anand K.
    Sinha, Kundan
    DIABETES, 2013, 62 : A95 - A95
  • [4] Efficacy of Sitagliptin When Added to Ongoing Therapy in Korean Subjects with Type 2 Diabetes Mellitus
    Chung, Hye Soo
    Lee, Moon-Kyu
    DIABETES & METABOLISM JOURNAL, 2011, 35 (04) : 411 - 417
  • [5] Efficacy and safety of sitagliptin when added to ongoing metformin therapy in patients with type 2 diabetes
    Scott, R.
    Loeys, T.
    Davies, M. J.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (10): : 959 - 969
  • [6] Efficacy and safety of coadministration of sitagliptin with insulin glargine in type 2 diabetes
    Cao, Ying
    Gao, Fang
    Zhang, Qian
    Xu, Lingling
    Wan, Qian
    Li, Wenqi
    Li, Jimin
    Wang, Ling
    Xue, Yaoming
    JOURNAL OF DIABETES, 2017, 9 (05) : 502 - 509
  • [7] Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2 diabetes
    Scott, Russell
    Loeys, Tom
    Davies, Michael J.
    Engel, Samuel S.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S32 - S32
  • [8] Sitagliptin and insulin therapy in Type 2 diabetes
    Rai, R.
    Lomova-Williams, L.
    Benjamin, S.
    Mallipedhi, A.
    Price, D. E.
    Stephens, J. W.
    DIABETIC MEDICINE, 2013, 30 : 163 - 164
  • [9] Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy
    Kadowaki T.
    Tajima N.
    Odawara M.
    Minamide T.
    Kawashima M.
    Yanagida D.
    Okamoto T.
    Arjona Ferreira J.C.
    Diabetology International, 2013, 4 (3) : 160 - 172
  • [10] 2.2 Study of Efficacy and Safety of Sitagliptin in Patients of Type 2 Diabetes when Added to Insulin Therapy Alone or With Metformin (373-OR)
    Devendra P. Singh
    Anand K. Srivastava
    Kundan Sinha
    Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 82 - 83
12345